Financials TruBridge, Inc.

Equities

TBRG

US2053061030

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
8.04 USD +2.42% Intraday chart for TruBridge, Inc. -2.78% -28.21%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 365.1 378.3 420 387.3 159.1 115 -
Enterprise Value (EV) 1 465.6 442.5 408.5 380.3 155.3 109 109.6
P/E ratio 18.5 x 27.4 x 23.3 x 25.2 x -3.56 x -15.6 x -65.6 x
Yield 1.52% 1.12% - - - - -
Capitalization / Revenue 1.33 x 1.43 x 1.5 x 1.19 x 0.47 x 0.33 x 0.31 x
EV / Revenue 1.7 x 1.67 x 1.46 x 1.16 x 0.46 x 0.32 x 0.3 x
EV / EBITDA 9.32 x 10.2 x 7.76 x 6.8 x 3.26 x 2.36 x 2 x
EV / FCF 11.1 x 9.66 x - - - 20.7 x 9.21 x
FCF Yield 8.99% 10.4% - - - 4.84% 10.9%
Price to Book 1.97 x 1.94 x 1.88 x 1.7 x 0.86 x 0.6 x 0.6 x
Nbr of stocks (in thousands) 13,830 14,095 14,334 14,228 14,205 14,310 -
Reference price 2 26.40 26.84 29.30 27.22 11.20 8.040 8.040
Announcement Date 2/11/20 2/9/21 2/15/22 2/14/23 2/29/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 274.6 264.5 280.6 326.6 339.4 344 367.4
EBITDA 1 49.96 43.39 52.68 55.9 47.58 46.26 54.78
EBIT 1 24.58 21.05 24.71 22.78 -42.6 5.47 11.76
Operating Margin 8.95% 7.96% 8.8% 6.97% -12.55% 1.59% 3.2%
Earnings before Tax (EBT) 1 23.7 18.78 23.08 18.08 -54.38 -8.41 -2.115
Net income 1 20.47 14.25 18.43 15.87 -45.79 -2.925 2.998
Net margin 7.45% 5.39% 6.57% 4.86% -13.49% -0.85% 0.82%
EPS 2 1.430 0.9800 1.260 1.080 -3.150 -0.5156 -0.1226
Free Cash Flow 1 41.84 45.81 - - - 5.276 11.9
FCF margin 15.24% 17.32% - - - 1.53% 3.24%
FCF Conversion (EBITDA) 83.75% 105.58% - - - 11.41% 21.72%
FCF Conversion (Net income) 204.42% 321.54% - - - - 396.89%
Dividend per Share 2 0.4000 0.3000 - - - - -
Announcement Date 2/11/20 2/9/21 2/15/22 2/14/23 2/29/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 70.09 74 77.87 82.73 82.83 83.22 86.23 84.62 82.71 85.87 83.02 84.48 86.78 89.72 89
EBITDA 1 12.24 14.32 16.15 13.17 - - 14.64 11.23 9.722 11.98 8.96 9.289 12.84 15.17 12.38
EBIT 1 4.531 7.525 8.986 4.588 4.943 4.266 6.295 -1.906 -5.213 -41.78 -0.9076 -1.19 2.876 4.692 0.8612
Operating Margin 6.46% 10.17% 11.54% 5.55% 5.97% 5.13% 7.3% -2.25% -6.3% -48.66% -1.09% -1.41% 3.31% 5.23% 0.97%
Earnings before Tax (EBT) 1 3.829 6.982 9.476 3.839 2.938 1.827 3.893 -4.492 -8.06 -45.72 -4.378 -4.66 -0.5942 1.222 -2.609
Net income 1 2.744 5.401 8.113 3.076 2.161 2.517 3.084 -2.837 -3.562 -42.47 -2.789 -3.235 0.7318 2.367 -1.109
Net margin 3.91% 7.3% 10.42% 3.72% 2.61% 3.02% 3.58% -3.35% -4.31% -49.46% -3.36% -3.83% 0.84% 2.64% -1.25%
EPS 2 0.1900 0.3700 0.5500 0.2100 0.1500 0.1700 0.2100 -0.2000 -0.2400 -2.920 -0.2988 -0.2290 -0.0549 0.0645 -0.1426
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/9/21 2/15/22 5/3/22 8/2/22 11/1/22 2/14/23 5/9/23 8/9/23 11/8/23 2/29/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 101 64.1 - - - - -
Net Cash position 1 - - 11.4 6.95 3.85 6.07 5.49
Leverage (Debt/EBITDA) 2.012 x 1.478 x - - - - -
Free Cash Flow 1 41.8 45.8 - - - 5.28 11.9
ROE (net income / shareholders' equity) 11.9% 7.41% 8.72% 6.99% -21.9% -0.58% 0.47%
ROA (Net income/ Total Assets) 6.13% 4.28% 5.19% 3.9% -10.6% -0.25% 0.21%
Assets 1 333.9 332.9 354.8 407.2 432.6 1,163 1,450
Book Value Per Share 2 13.40 13.80 15.60 16.10 13.00 13.40 13.30
Cash Flow per Share 2 3.160 3.500 3.270 2.260 0.0700 1.540 1.370
Capex 1 1.76 3.34 - 62.7 60.1 24.6 23.1
Capex / Sales 0.64% 1.26% - 19.2% 17.71% 7.14% 6.29%
Announcement Date 2/11/20 2/9/21 2/15/22 2/14/23 2/29/24 - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
8.04 USD
Average target price
14 USD
Spread / Average Target
+74.13%
Consensus
  1. Stock Market
  2. Equities
  3. TBRG Stock
  4. Financials TruBridge, Inc.